CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 15 enrolled
Drug / intervention
Mucinex®drug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02859246
NCT02859246N/ACompleted
CompareCT.gov

Mucinex® for Treatment of Filamentary Keratitis

Massachusetts Eye and Ear Infirmary·interventional·Posted Aug 9, 2016·Updated Feb 19, 2020

In Brief

A clinical study evaluating Mucinex® for Filamentary Keratitis. Completed, enrolled 15 participants across 1 site.

Detailed Summary

It is a pilot study aimed to determine if oral Mucinex® is effective in reducing the amount of corneal filaments and improving symptomology in subjects with filamentary keratitis.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsFilamentary Keratitis
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedAug 9, 2016
Enrollment StartSep 1, 2016
Primary CompletionJul 1, 2018
TodayJul 2, 2026
Enrollment to primary: 1.8 yearsPosted 9.9 years ago

Interventions

Mucinex®drug

Mucinex®